Intralesional administration of human recombinant epidermal growth factor improves healing and reduces amputations in patients with severe diabetic foot ulcers

Publication date: Available online 31 March 2017 Source:Current Therapeutic Research Author(s): Aristides L. Garcia Herrera
Source: Current Therapeutic Research - Category: Drugs & Pharmacology Source Type: research